Claritev Corporation (CTEV) Stock

About Claritev Corporation

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

Claritev Corporation is led by CEO Travis S. Dalton, publicly traded since 2020.

Claritev Corporation (CTEV) stock trades at $23.50 with a market capitalization of $398.27M. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.41, reflecting a net loss over the last twelve months, a negative price-to-book of -1.38, reflecting negative shareholders' equity, price-to-sales of 0.41. Over the past 52 weeks the stock has ranged between $11.50 and $73.68, and currently trades 68.1% below its 52-week high.

On profitability, Claritev Corporation generates a return on equity (ROE) of 139.56% (not meaningful, as shareholders' equity is negative), return on capital employed of 1.08%, an operating margin of 4.66%, a net profit margin of -28.46%.

Official website: www.claritev.com

Claritev Corporation by the numbers, 2018–2025

Between 2018 and 2025 Claritev Corporation reported revenue of $1.0B rising to $965.0M, a change of -7.3% across 8 years. Compounded, revenue has grown 0.6% a year over five years, -3.7% over three, 3.6% over the last twelve months. Net profit fell to $-284.0M.

Operating margin went from 41.1% in 2018 to 4.7% in 2025, a fall of 36.4 percentage points. The most recent net margin is -28.46%. On a trailing twelve-month basis to Jun '26, revenue is $995.0M and net profit $-284.0M.

Borrowings stand at $4.6B, cash from operations was $117.0M in the latest year, positive in 8 of the last 8.

Return on equity has averaged -365.9% over five years, and was 163.2% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Claritev Corporation (CTEV) — frequently asked questions